In contrast to these studies, Ojea Calvo et al [159] suggested that Ki-67 expression (3%) in preoperative biopsies is less effective than classic factors such as PSA, Gleason score, and pT classification in predicting prostate cancer biochemical progression after radical prostatectomy. The gene discussed is MKI67; the disease is prostate cancer.